short selling action, page-9

Hypergoldie you said

"Also, they won't get approval from FDA on mar 18 (IMO) as they can't re-submit after their original submission so they have to approve the whole lot rather than 18+, its just the way the FDA works...they will have to re-submit and probably do it a few months after maybe Oct and hopefully no extra trials."

Regarding Resubmitting - Do you know this for a fact as it goes against what Dr Alan Robertson said in the last teleconferance and as reported in the Fin Review story I put up a while back?